Sabar Karimah Es sold CAPR
March 31, 2026 · Form 4 insider transaction
Sabar Karimah Es sold 61,265 shares of Capricor Therapeutics, Inc. at $30.17 per share, a transaction worth $1.85M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
61,265
Price
$30.17
Total value
$1.85M
InsiderSabar Karimah Es
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 31, 2026
Filing dateApril 1, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.; The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.46, inclusive.